当前位置:首页 - 行情中心 - 康缘药业(600557) - 财务分析 - 现金流量表

康缘药业

(600557)

  

流通市值:84.30亿  总市值:84.30亿
流通股本:5.66亿   总股本:5.66亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,712,758,668.071,723,844,181.66953,254,042.374,798,339,944.51
  收到其他与经营活动有关的现金149,901,098.29117,947,310.7143,558,462.11171,910,000.44
  经营活动现金流入小计2,862,659,766.361,841,791,492.37996,812,504.484,970,249,944.95
  购买商品、接受劳务支付的现金468,856,439.38283,359,381.35152,193,982.181,018,162,573.13
  支付给职工以及为职工支付的现金545,390,647.88385,204,801.72204,596,494.96799,179,546.38
  支付的各项税费231,771,114.27154,041,403.1111,189,480.48416,702,530.54
  支付其他与经营活动有关的现金1,270,516,658.45874,837,758.35451,896,447.582,033,717,090.59
  经营活动现金流出小计2,516,534,859.981,697,443,344.52919,876,405.24,267,761,740.64
  经营活动产生的现金流量净额346,124,906.38144,348,147.8576,936,099.28702,488,204.31
二、投资活动产生的现金流量:
  收回投资收到的现金489,014,448.79388,014,448.79228,014,448.792,050,000,000
  取得投资收益收到的现金4,924,048.574,868,653.23817,664.3622,560,575.99
  处置固定资产、无形资产和其他长期资产收回的现金净额1,953,146.28179,7086,376.99,180,155.2
  处置子公司及其他营业单位收到的现金净额---10,252,391.02
  投资活动现金流入小计495,891,643.64393,062,810.02228,838,490.052,091,993,122.21
  购建固定资产、无形资产和其他长期资产支付的现金335,663,338.82206,728,048.2796,561,280.69476,685,222.49
  投资支付的现金493,600,000413,600,000282,830,027.51,630,000,000
  投资活动现金流出小计829,263,338.82620,328,048.27379,391,308.192,106,685,222.49
  投资活动产生的现金流量净额-333,371,695.18-227,265,238.25-150,552,818.14-14,692,100.28
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金---40,672,313.39
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---40,672,313.39
  分配股利、利润或偿付利息支付的现金---218,298,792.86
  其中:子公司支付给少数股东的股利、利润---4,719,600
  支付其他与筹资活动有关的现金23,149,927.5523,172,212.9-324,496,599.51
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计23,149,927.5523,172,212.9-542,795,392.37
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-23,149,927.55-23,172,212.9--502,123,078.98
四、汇率变动对现金及现金等价物的影响-8,216.49-2,001.517,325.33147,221.47
五、现金及现金等价物净增加额-10,404,932.84-106,091,304.81-73,609,393.53185,820,246.52
  加:期初现金及现金等价物余额2,167,781,487.342,167,781,487.342,167,781,487.341,981,961,240.82
  期末现金及现金等价物余额2,157,376,554.52,061,690,182.532,094,172,093.812,167,781,487.34
补充资料:
  净利润-148,708,370.27-380,923,009.12
  资产减值准备---20,741,965.38
  固定资产和投资性房地产折旧-85,671,153.44-171,778,299.84
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-85,671,153.44-171,778,299.84
  无形资产摊销-10,382,534.04-27,863,992.28
  长期待摊费用摊销-2,557,464.44-5,114,928.87
  处置固定资产、无形资产和其他长期资产的损失-20,480.39--703,946.92
  固定资产报废损失-857,739.65-1,806,344.63
  财务费用-6,038,618.69-22,149,819.94
  投资损失--4,800,451--20,900,933.05
  递延所得税--4,457,384.06--1,979,649.75
  其中:递延所得税资产减少--4,457,384.06--1,979,649.75
  存货的减少-87,260,451.13--210,903,541.98
  经营性应收项目的减少--78,605,903.78-426,774,750.99
  经营性应付项目的增加--110,464,615.48--116,936,719.29
  现金的期末余额-2,061,690,182.53-2,167,781,487.34
  减:现金的期初余额-2,167,781,487.34-1,981,961,240.82
  现金及现金等价物的净增加额--106,091,304.81-185,820,246.52
公告日期2025-10-312025-08-282025-04-302025-04-03
审计意见(境内)标准无保留意见
TOP↑